| scholarly article | Q13442814 |
| P2093 | author name string | Hyun Kyung Kim | |
| Jun-Ho Chung | |||
| Kyung Soon Song | |||
| Kyoung Rhan Lee | |||
| Se-Na Lee | |||
| P2860 | cites work | Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 | Q24314828 |
| Platelet-released phospholipids link haemostasis and angiogenesis | Q31882372 | ||
| Platelet microparticles: a wide-angle perspective | Q33706238 | ||
| Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology | Q34916031 | ||
| Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? | Q34988256 | ||
| HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway | Q39946864 | ||
| Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells | Q40729733 | ||
| Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. | Q40845943 | ||
| Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway | Q40969063 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations | Q44077533 | ||
| Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon | Q45749666 | ||
| p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. | Q50336697 | ||
| Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. | Q53660624 | ||
| Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3 | Q56706046 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 376-384 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Platelet microparticles induce angiogenesis in vitro | |
| P478 | volume | 124 |
| Q38443364 | A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy |
| Q35204306 | Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia |
| Q36030398 | Angiogenesis: a link to thrombosis in athero-thrombotic disease. |
| Q33774257 | Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material |
| Q34635182 | Arterial and venous thrombosis in cancer patients |
| Q39025587 | Assays to examine endothelial cell migration, tube formation, and gene expression profiles |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q46283813 | Bone formation in peri-implant defects grafted with microparticles: a pilot animal experimental study |
| Q33917557 | CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation |
| Q37558436 | Cancer and Thrombosis: The Platelet Perspective. |
| Q34442188 | Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy |
| Q36832898 | Cell-derived microparticles and exosomes in neuroinflammatory disorders |
| Q37295504 | Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? |
| Q59152443 | Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes |
| Q42513574 | Circulating endothelial cells and microparticles for prediction of tumor progression and outcomes in advanced non-small cell lung cancer |
| Q33908558 | Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer |
| Q39413926 | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity |
| Q35737756 | Circulating membrane-derived microvesicles in redox biology |
| Q37782534 | Clinical relevance of microparticles from platelets and megakaryocytes |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q36580760 | Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. |
| Q38918385 | Detection of platelet vesicles by flow cytometry. |
| Q48282416 | Divergent endothelial function but similar platelet microvesicle responses following eccentric and concentric cycling at a similar aerobic power output. |
| Q21245238 | Evidence of platelet activation in multiple sclerosis |
| Q48255690 | Exercise intensity modulates the appearance of circulating microvesicles with proangiogenic potential upon endothelial cells |
| Q57166259 | Exercise-Derived Microvesicles: A Review of the Literature |
| Q38994668 | Exosomes and Cardiovascular Protection. |
| Q38908954 | Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure |
| Q90379847 | Extracellular Vesicles as Mediators of Cellular Crosstalk Between Immune System and Kidney Graft |
| Q33663907 | Extracellular Vesicles in Angiogenesis. |
| Q56358143 | Extracellular Vesicles: A Novel Target for Exercise-Mediated Reductions in Type 2 Diabetes and Cardiovascular Disease Risk |
| Q39107240 | Extracellular vesicles and blood diseases |
| Q39453434 | Extracellular vesicles in renal disease |
| Q33384849 | Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2 |
| Q45407992 | Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. |
| Q33518352 | Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation |
| Q45991393 | Independent motile microplast formation correlates with glioma cell invasiveness. |
| Q37209762 | Inflammatory angiogenesis in atherogenesis--a double-edged sword |
| Q38689619 | Influence of red blood cell-derived microparticles upon vasoregulation |
| Q46387376 | Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway |
| Q40043141 | Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways |
| Q30485800 | Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles |
| Q36816361 | Microparticles as novel biomarkers and therapeutic targets in coronary heart disease |
| Q38334501 | Microparticles as potential biomarkers of cardiovascular disease |
| Q39603636 | Microparticles in tumor progression. |
| Q38012180 | Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging |
| Q36745194 | Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets |
| Q26770233 | Microvesicles and exosomes: new players in metabolic and cardiovascular disease |
| Q49741768 | Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse |
| Q43182095 | New frontiers for platelet CD154. |
| Q35862798 | Paracrine induction of endothelium by tumor exosomes. |
| Q91979008 | Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients |
| Q91979012 | Pathophysiology 2: The Role of Platelets in Cancer Biology |
| Q37267758 | Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus |
| Q49495752 | Physiologic Impact of Circulating RBC Microparticles upon Blood-Vascular Interactions |
| Q52643454 | Platelet Microparticles and miRNA Transfer in Cancer Progression: Many Targets, Modes of Action, and Effects Across Cancer Stages. |
| Q38674677 | Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. |
| Q38323512 | Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease |
| Q48683822 | Platelet microparticles promote neural stem cell proliferation, survival and differentiation |
| Q39094993 | Platelet microvesicles in health and disease |
| Q47106708 | Platelet-Derived Microvesicles in Cardiovascular Diseases. |
| Q38003425 | Platelet-associated angiogenesis regulating factors: a pharmacological perspective |
| Q48667116 | Platelet-derived extracellular vesicles in plateletpheresis concentrates as a quality control approach |
| Q38717559 | Platelet-derived microparticles and soluble factors differentially regulate human endometrial epithelial cell movement |
| Q37479125 | Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. |
| Q91870457 | Platelets and Platelet-Derived Extracellular Vesicles in Liver Physiology and Disease |
| Q38691783 | Platelets and cancer angiogenesis nexus. |
| Q33369958 | Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage |
| Q38543319 | Platelets and their microparticles as key players in pathophysiological responses |
| Q38729940 | Platelets are a possible regulator of human endometrial re-epithelialization during menstruation. |
| Q35904932 | Platelets at the interface of thrombosis, inflammation, and cancer. |
| Q38038134 | Platelets: key players in vascular inflammation |
| Q50312260 | Proteomic and functional characterisation of platelet microparticle size classes. |
| Q28069254 | Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis |
| Q38429809 | Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia. |
| Q38202537 | Small but mighty: microparticles as mediators of tumor progression |
| Q92535745 | The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair |
| Q37129768 | The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis. |
| Q52719266 | The Platelet Lifeline to Cancer: Challenges and Opportunities. |
| Q28066054 | The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression |
| Q38212058 | The functional role of platelets in the regulation of angiogenesis |
| Q39032612 | The role of platelet microvesicles in intercellular communication. |
| Q33803558 | The role of platelets in tumour growth |
| Q37421157 | Therapeutic potential of plasma membrane-derived microparticles |
| Q80088629 | [Markers of thrombotic disease: procoagulant microparticles] |
| Q53787748 | [Resistance to anti-angiogenic therapy: a clinical and scientific current issue]. |
Search more.